Please assess the completion status of the following clinical trial:

Trial Title: Investigation of Efficacy and Outcome of a New Medical Device for Treatment of Migraine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female or male subjects, in otherwise good health, 20 to 55 years of age~* Subjects who meet the ICHD-2 (2nd Edition of The International Headache Classification) criteria for migraine headache~* Subjects with a minimum of 1 migraine attack per month~* Attack duration of 4 to 72 hours~* Normal attack intensity of at least 4 on a 0-10 VAS-scale~Exclusion Criteria:~* Completed heart surgery~* Cardiovascular diseases~* Vascular damages on neck vessels~* Diseases other than migraine of the CNS~* Severe disease of vital body organs~* Severe psychiatric disorders~* More than 6 migraine attacks per month

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Migraine medical device (Type: EXPERIMENTAL): Treatment with an active nasal probe
- Inactive migraine medical device (Type: PLACEBO_COMPARATOR): Treatment with an inactive nasal probe.

Based on this trial design, predict the completion outcome and termination type (if applicable).